Antithrombin in Extracorporeal Membrane Oxygenation: To Replenish or Not to Replenish?
- PMID: 33731637
- DOI: 10.1097/CCM.0000000000004812
Antithrombin in Extracorporeal Membrane Oxygenation: To Replenish or Not to Replenish?
Conflict of interest statement
The authors have disclosed that they do not have any potential conflicts of interest.
Comment on
-
A Randomized Controlled Trial of Antithrombin Supplementation During Extracorporeal Membrane Oxygenation.Crit Care Med. 2020 Nov;48(11):1636-1644. doi: 10.1097/CCM.0000000000004590. Crit Care Med. 2020. PMID: 32947474 Clinical Trial.
References
-
- Panigada M, Cucino A, Spinelli E, et al. A randomized controlled trial of antithrombin supplementation during extracorporeal membrane oxygenation. Crit Care Med. 2020; 48:1636–1644
-
- Byrnes J, Swearingen C, Prodhan P, et al. Antithrombin III supplementation on extracorporeal membrane oxygenation: Impact on heparin dose and circuit life. ASAIO J. 2014; 60:57–62
-
- Extracorporeal Life Support OrganizationAnticoagulation Task force - ELSO Anticoagulation Guideline. 2014Available at: https://www.elso.org/Portals/0/Files/elsoanticoagulationguideline8-2014-... . Accessed November 1, 2020
-
- Chlebowski MM, Baltagi S, Carlson M, et al. Clinical controversies in anticoagulation monitoring and antithrombin supplementation for ECMO. Crit Care. 2020; 24:19
-
- Garcia DA, Baglin TP, Weitz JI, et al. Parenteral anticoagulants: Antithrombotic therapy and prevention of thrombosis, 9 th ed: American College of chest physicians evidence-based clinical practice guidelines. Chest. 2012; 141:e24S–e43S
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources